UAB News December 23, 2021 Michael Stalvey, M.D. Dr. Stalvey selected for Executive Committee for ResearchCon 2022 UAB News November 23, 2021 Michael Stalvey, M.D. Drs. Richter, Stalvey and Walley ...
Since the Cystic Fibrosis Center opened 60 years ago, the outlook has changed dramatically for patients like Livingston. Once expected to survive only a few years at most, most are now living into ...
DANVILLE — Geisinger Medical Center’s pediatric and adult cystic fibrosis (CF) programs were both selected as 2023 recipients of the annual Cystic Fibrosis Foundation’s Quality Improvement Award for ...
BUFFALO, N.Y. – Cystic fibrosis is a genetic, progressive disease that causes persistent lung infections and impacts the most basic physical processes. While recent breakthroughs have significantly ...
Cystic fibrosis remains an incurable genetic disorder which impairs lung function and significantly reduces life expectancy. A new combination drug therapy which addresses the disorder's underlying ...
In 1938, Dr. Dorothy Hansine Andersen described a new disease that caused the deaths of children she treated. She called it cystic fibrosis (CF). CF is a genetic condition that occurs due to ...
Among pediatric and adult patients with cystic fibrosis, the average number of chronic respiratory therapies used fell after ...
The UAB Gregory Fleming James Cystic Fibrosis Research Center is a university-wide interdisciplinary research center funded by the National Institutes of Health, the Cystic Fibrosis Foundation and ...
The Minnesota Cystic Fibrosis Center recently gained membership to a research network for the disease, creating greater opportunities to treat patients in the Midwest and across the nation. The center ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback